Monday, Oct 24th

Last update05:20:13 AM GMT

You are here News Health As drug industry’s influence over research grows, so does the potential for bias

As drug industry’s influence over research grows, so does the potential for bias

E-mail Print PDF

drug companiesFor drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.

“We now have clear evidence from a large international study that the initial use of [Avandia] is more effective than standard therapies,” a senior vice president of GlaxoSmithKline, Lawson Macartney, said in a news release.

What only careful readers of the article would have gleaned is the extent of the financial connections between the drugmaker and the research. The trial had been funded by GlaxoSmithKline, and each of the 11 authors had received money from the company. Four were employees and held company stock. The other seven were academic experts who had received grants or consultant fees from the firm.

Whether these ties altered the report on Avandia may be impossible for readers to know. But while sorting through the data from more than 4,000 patients, the investigators missed hints of a danger that, when fully realized four years later, would lead to Avandia’s virtual disappearance from the United States:



Most Recent Related Stories...

Americans overwhelmingly support abortion rights

Americans support abortion rightsPolitical candidates, consultants and the media generally misunderstand the politics of abortion rights. They tend to...

France to open first safe-injection room for drug addicts

safe heroin injection room opened in FranceFrance will open its first safe-injection room for drug addicts despite years of efforts by conservatives...

St. Jude warns of heart-device battery issue linked to two deaths

St. Jude'sSt. Jude Medical Inc warned on Tuesday that some of its implanted heart devices were at...

EpiPen maker Mylan to pay $465M to settle claims it overbilled Medicaid

Mylan to pay for Medicaid fraudEmbattled pharmaceutical company Mylan agreed Friday to pay nearly a half-billion dollars to settle claims that...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!